STO:ODI

ODI Pharma AB · STO · Healthcare · SEK · FY for 2026

Figures on this page computed 2026-11-08 12:42 UTC

Last close

n/aSEK

Market data

14.4xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
SEK
- computed
- Computed from the filing for 2026
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
SEK
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
6.0%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
SEK
- Computed from the filing for 2026
- Computed from the filing for 2026
13.9%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
SEK
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
SEK
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
SEK
- computed

Safety is the furthest below its sector's middle: 0.46 against 0.63 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

2.80x

-0.51x

-1.17x

n/a

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2026

Computed2026

Computed2026

Computed2026

Market datan/a

Each against its own average

3 of 5 read

Except where said otherwise: Computed from the filing for 2026

Sales2.80x
Its own average over 5 years, 11.8M.
Profit-0.51x
Its own average over 8 years, -3.9M.
Free cash flow-1.17x
Its own average over 8 years, -3.9M.
Debtn/a
Its own average over 0 years.
Pricen/a
Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at -1.17 times.

Sales is 2.80 times its own 5-year average; Profit is -0.51 times its own 8-year average; Free cash flow is -1.17 times its own 8-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2026

Sales against its own 5-year average2.80
Source
computed
Statement
income
Fiscal year
2026
Reported in
SEK
Profit against its own 8-year average-0.51
Source
computed
Statement
income
Fiscal year
2026
Reported in
SEK
Free cash flow against its own 8-year average-1.17
Source
computed
Statement
income
Fiscal year
2026
Reported in
SEK
Debt against its own 0-year averagen/a
Not held.
Source
computed
Statement
income
Fiscal year
2026
Reported in
SEK
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
SEK